These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31853206)

  • 1. The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density.
    Fattahi MR; Niknam R; Shams M; Anushiravani A; Taghavi SA; Omrani GR; Mahmoudi L
    Risk Manag Healthc Policy; 2019; 12():349-355. PubMed ID: 31853206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors use and change in bone mineral density.
    Arj A; Razavi Zade M; Yavari M; Akbari H; Zamani B; Asemi Z
    Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).
    Targownik LE; Leslie WD; Davison KS; Goltzman D; Jamal SA; Kreiger N; Josse RG; Kaiser SM; Kovacs CS; Prior JC; Zhou W;
    Am J Gastroenterol; 2012 Sep; 107(9):1361-9. PubMed ID: 22777336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors.
    Bahtiri E; Islami H; Hoxha R; Qorraj-Bytyqi H; Rexhepi S; Hoti K; Thaçi K; Thaçi S; Karakulak Ç
    J Bone Miner Metab; 2016 Sep; 34(5):571-9. PubMed ID: 26209167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?
    Aasarød KM; Mosti MP; Finstad MT; Stunes AK; Fossmark R; Syversen U
    Bone Rep; 2021 Jun; 14():101095. PubMed ID: 34095362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.
    Jiang Y; Zhang Y; Jin M; Gu Z; Pei Y; Meng P
    PLoS One; 2015; 10(6):e0130400. PubMed ID: 26090818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone density in proton pump inhibitors users: a prospective study.
    Ozdil K; Kahraman R; Sahin A; Calhan T; Gozden EH; Akyuz U; Erer B; Sokmen MH
    Rheumatol Int; 2013 Sep; 33(9):2255-60. PubMed ID: 23455632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.
    Targownik LE; Lix LM; Leung S; Leslie WD
    Gastroenterology; 2010 Mar; 138(3):896-904. PubMed ID: 19931262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study.
    Solomon DH; Diem SJ; Ruppert K; Lian YJ; Liu CC; Wohlfart A; Greendale GA; Finkelstein JS
    J Bone Miner Res; 2015 Feb; 30(2):232-9. PubMed ID: 25156141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.
    Targownik LE; Goertzen AL; Luo Y; Leslie WD
    Am J Gastroenterol; 2017 Jan; 112(1):95-101. PubMed ID: 27845341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density in rural Thai adults living in Khon Kaen province.
    Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
    J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Bone Mineral Density Scores and Proton Pump Inhibitors Use in the Elderly.
    Amoako AO; Jafilan L; Nasiri P; Pujalte GG
    Curr Rheumatol Rev; 2016; 12(2):162-6. PubMed ID: 26496778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.
    Hämäläinen H; Kaarela K; Kröger H; Kauppi M; Järvenpää S; Hakala M; Kotaniemi A
    Joint Bone Spine; 2007 Oct; 74(5):482-7. PubMed ID: 17905634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss with antiepileptic drug therapy: a twin and sibling study.
    Shiek Ahmad B; Petty SJ; Gorelik A; O'Brien TJ; Hill KD; Christie JJ; Sambrook PN; Wark JD
    Osteoporos Int; 2017 Sep; 28(9):2591-2600. PubMed ID: 28589417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients.
    Kirkpantur A; Altun B; Arici M; Turgan C
    Int J Clin Pract; 2009 Feb; 63(2):261-8. PubMed ID: 19196364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.
    Maggio M; Lauretani F; Ceda GP; De Vita F; Bondi G; Corsonello A; Cattabiani C; Lattanzio F; Ruggiero C; Nouvenne A; Meschi T; Bandinelli S; Ferrucci L
    Bone; 2013 Dec; 57(2):437-42. PubMed ID: 24076021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
    El-Desouki MI; Sherafzal MS; Othman SA
    Saudi Med J; 2005 Sep; 26(9):1346-50. PubMed ID: 16155646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.